This webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Colorectal, Hepatocellular, Pancreatic, and Gastric/Esophageal Cancers.

This webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Colorectal, Hepatocellular, Pancreatic, and Gastric/Esophageal Cancers.

This educational program is designed specifically to address the interests of managed care and corporate medical directors. Each webinar will feature a different topic based on feedback from a sample of medical directors along with an interactive question and answer period for participants.

This educational program is designed specifically to address the interests of managed care and corporate medical directors. Each webinar will feature a different topic based on feedback from a sample of medical directors along with an interactive question and answer period for participants.

This webinar is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Acute Myeloid Leukemia (AML).

This webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Sarcomas (Soft Tissue and Bone).

This webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Sarcomas (Soft Tissue and Bone).

This webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Sarcomas (Soft Tissue and Bone).

This webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Sarcomas (Soft Tissue and Bone).

This webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Sarcomas (Soft Tissue and Bone).